Items where Author is "Travers, PJ"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 12.

Journal article

De, La, Madrigal, JA, Rusakiewicz, S, Bencsik, M ORCID: 0000-0002-6278-0378, Cave, GWV ORCID: 0000-0002-4167-1332, Selman, A, Rees, RC, Travers, PJ and Dodi, IA, 2009. Artificial exosomes as tools for basic and clinical immunology. Journal of Immunological Methods, 344 (2), pp. 121-132. ISSN 0022-1759

De, La, Madrigal, JA, Benesik, M, Cave, GWV ORCID: 0000-0002-4167-1332, Selman, A, Rees, RC, Travers, PJ and Dodi, IA, 2006. Artificial super para magnetic nano APC for active and adoptive immunotherapy. Blood, 108 (11). ISSN 0006-4971

De, La, Madrigal, JA, Bencsik, M ORCID: 0000-0002-6278-0378, Cave, GWV ORCID: 0000-0002-4167-1332, Rees, RC, Travers, PJ and Dodi, IA, 2005. Hemato nanotechnology: artificial APC system for T cell adoptive and active immunotherapy. Blood, 106 (11), p. 3907.

De, La, Madrigal, JA, Bencsik, M ORCID: 0000-0002-6278-0378, Cave, GWV ORCID: 0000-0002-4167-1332, Rees, RC, Travers, PJ and Dodi, IA, 2005. Hemato nanotechnology: artificial APC system for T cell adoptive and active immunotherapy. Blood, 106 (11), p. 3907. ISSN 0006-4971

Madrigal, JA, Travers, PJ and Dodi, IA, 2005. Immunotherapeutic aspects of stem cell transplantation. Hematology, 10, pp. 289-292. ISSN 1024-5332

Rusakiewicz, S, Dodi, IA, Loconto, J, Travers, PJ and Madrigal, JA, 2004. Can BCR/ABL breakpoint fusion peptides be used as a target for GVL immunotherapy by expanding peptide specific T cells in patients in vivo? Blood Cells Molecules and Diseases, 33 (3), p. 191. ISSN 1079-9796

Dodi, IA, Rusakiewicz, S, Aubert, G, Clarke, R, Christmas, S, Creaser, C, Bonner, P, Rees, R, Travers, PJ and Madrigal, JA, 2002. Definition of the breakpoint fusion peptides for HLA-A3 and HLA-B8 in CML cells. Tissue Antigens, 59, p. 45. ISSN 0001-2815

Aubert, G, Hassan-Walker, AF, Madrigal, JA, Emery, VC, Morte, C, Grace, S, Koh, MBC, Potter, M, Prentice, HG, Dodi, IA and Travers, PJ, 2001. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. Journal of Infectious Diseases, 184 (8), pp. 955-963. ISSN 0022-1899

Clark, RE, Dodi, IA, Hill, SC, Lill, JR, Aubert, G, Macintyre, AR, Rojas, J, Bourdon, A, Bonner, PLR ORCID: 0000-0001-9015-3403, Wang, LH, Christmas, SE, Travers, PJ, Creaser, CS, Rees, RC and Madrigal, JA, 2001. Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood, 98 (10), pp. 2887-2893. ISSN 0006-4971

Morte, C, Dodi, IA, Morgan, CL, Pay, AL, Travers, PJ and Madrigal, JA, 1999. Release of IFN gamma by NK and T-cells as a measure of the immune response to CMV infection in CMV-positive and CMV-negative individuals. Blood, 94 (10). ISSN 0006-4971

Conference contribution

De, La, Madrigal, JA, Bencsik, M ORCID: 0000-0002-6278-0378, Cave, GWV ORCID: 0000-0002-4167-1332, Rees, RC, Travers, PJ and Dodi, IA, 2005. Hemato nanotechnology: artificial APC system for T cell adoptive and active immunotherapy. In: 47th Annual Meeting of the American Society of Hematology, Atlanta, GA, USA, 10-13 December 2005, Atlanta, GA, USA.

De, La, Madrigal, JA, Benesik, M, Cave, GWV ORCID: 0000-0002-4167-1332, Selman, A, Rees, RC, Travers, PJ and Dodi, IA, 2001. Artificial super para magnetic nano APC for active and adoptive immunotherapy. In: Symposium of the International Society of Molecular Evolution, Guananacaste, Costa Rica, 8-12 January 2001, Guananacaste, Costa Rica.

This list was generated on Fri Sep 22 04:38:33 2017 UTC.